查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1239511

按類型、應用和最終用戶分列的 PCA 泵（自調節鎮痛泵）市場：2021-2031 年全球機會分析和行業預測

Patient Controlled Analgesia Pumps Market By Type, By Application, By End user : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 235 Pages | 商品交期: 2-3個工作天內

價格

2021 年 PCA 泵（自調節鎮痛泵）市場規模為 2.7767 億美元，2022 年至 2031 年復合年增長率為 3.9%，預計 2031 年將達到 4.0789 億美元

PCA（自控鎮痛）是一種有效的疼痛管理技術，可讓患者控制疼痛。 這些泵提供阿片類止痛藥，例如氫嗎啡酮、芬太尼和嗎啡。 泵連接到靜脈管線 (IV)，這是一根插入靜脈的小軟管。 通常在按下按鈕時給藥。 這些泵是將藥物以受控量推入患者體內的醫療設備。 止痛泵越來越多地用於醫院、療養院和家庭等臨床環境。 用於給藥嗎啡、芬太尼和氫嗎啡酮等藥物。 PCA 泵的好處包括安全使用、患者滿意度、減少鎮靜、減少藥物劑量以及在泵空時提醒護理團隊。

PCA 配備了計算機控制的泵，常用於手術後康復的患者。 它用於術後管理。 這是一種讓患者有能力控制疼痛的方法。 PCA 對難以口服藥物的患者也有好處。 在某些情況下，患者可以設定自己的劑量並按下按鈕給自己額外的劑量。 PCA 藥物可以通過多種途徑給藥，包括口服、靜脈內、硬膜外、吸入、噴鼻和透皮。

PCA泵用於治療急性疼痛、慢性疼痛、手術後疼痛、分娩疼痛等，尤其適用於口服藥物給藥有困難的患者。 PCA 泵可用於治療初始住院阿片類藥物不足以緩解疼痛的急性疼痛病例。 常見的例子包括燒傷、外傷、胰腺炎和血管閉塞性疼痛危象。

PCA泵全球市場的增長是由於對鎮痛泵的需求不斷增加，以緩解癌症疼痛、骨科疾病、鐮狀細胞病等疼痛，以及需要鎮痛泵的外科手術數量不斷增加。主要原因是增加。 然而，新興國家缺乏對先進 PCA 泵的了解以及產品批准法規阻礙了市場增長。 相反，對 PCA 泵的需求增加和鎮痛泵的技術進步預計將為市場參與者提供有利可圖的機會。 由於疾病負擔的增加，存在用藥錯誤的可能性。 因此，需要更安全、更高效和標準化的先進遞送系統。 此外，先進的 PCA 泵的推出為市場提供了有利可圖的增長機會。

老年人口增加、慢性疼痛患病率上升和低成本等因素可能會推動市場發展。 此外，全球越來越多的人因癌症和其他疾病接受手術也可能對市場增長產生積極影響。 癌症、鐮狀細胞病和整形外科等疾病發病率的增加導致對 PCA 泵的需求增加。 例如，根據美國疾病控制與預防中心 (CDC) 的數據，估計到 2022 年 5 月將有大約 100,000 名美國人患有鐮狀細胞病。 因此，鐮狀細胞病患病率的上升增加了對 PCA 泵的吸收，推動了市場增長。

內容

第一章介紹

第 2 章執行摘要

第 3 章市場概述

  • 市場定義和範圍
  • 主要發現
    • 主要影響因素
    • 主要投資領域
  • 波特的五力分析
    • 供應商的議價能力
    • 買家的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 中等強度的競爭
  • 市場動態
    • 司機
      • 慢性疼痛疾病增加
      • 鎮痛泵的技術進步
      • 手術次數增加
    • 約束因素
      • 缺乏對鎮痛泵的認識
      • 嚴格的政府法規
    • 機會
      • 新興國家的有利增長機會
      • 止痛泵的開發
  • 分析 COVID-19 對市場的影響

第 4 章 PCA 泵（自調節鎮痛泵）市場，按類型

  • 概覽
    • 市場規模和預測
  • 電子和無線
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 機械
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 5 章 PCA 泵（自調節鎮痛泵）市場：按應用

  • 概覽
    • 市場規模和預測
  • 腫瘤和血液
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 消化系統
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 其他
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 6 章 PCA 泵（自調節鎮痛泵）市場：按最終用戶分類

  • 概覽
    • 市場規模和預測
  • 醫院
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 門診手術中心
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 其他
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 7 章 PCA 泵（自調節鎮痛泵）市場：按地區

  • 概覽
    • 市場規模和預測：按地區
  • 北美
    • 主要趨勢和機會
    • 市場規模和按類型預測
    • 市場規模和應用預測
    • 最終用戶的市場規模和預測
    • 市場規模和預測：按國家/地區分類
      • 美國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 加拿大
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 墨西哥
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
  • 歐洲
    • 主要趨勢和機會
    • 市場規模和按類型預測
    • 市場規模和應用預測
    • 最終用戶的市場規模和預測
    • 市場規模和預測：按國家/地區分類
      • 德國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 法國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 英國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 意大利
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 西班牙
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 其他歐洲
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
  • 亞太地區
    • 主要趨勢和機會
    • 市場規模和按類型預測
    • 市場規模和應用預測
    • 最終用戶的市場規模和預測
    • 市場規模和預測：按國家/地區分類
      • 日本
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 中國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 印度
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 澳大利亞
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 韓國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 其他亞太地區
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
  • 拉丁美洲/中東/非洲
    • 主要趨勢和機會
    • 市場規模和按類型預測
    • 市場規模和應用預測
    • 最終用戶的市場規模和預測
    • 市場規模和預測：按國家/地區分類
      • 巴西
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 沙特阿拉伯
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 南非
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測
      • 其他拉丁美洲/中東/非洲
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和應用預測
      • 最終用戶的市場規模和預測

第八章競爭格局

  • 介紹
  • 關鍵成功策略
  • 前 10 名玩家產品映射
  • 比賽儀表板
  • 競爭熱圖
  • 2021 年最佳球員排名

第九章公司簡介

  • Ace-medical
  • Arcomed AG
  • B. Braun SE
  • Becton, Dickinson and Company
  • Henan Tuoren Medical Device Co., Ltd.
  • ICU Medical, Inc.
  • Micrel Medical Devices SA
  • Fresenius SE and Co. KGaA
  • Changzhou Medical Bioengineering Co., Ltd.
  • SCW Medicath Ltd
Product Code: A13386

The patient controlled analgesia pumps market size valued for $277.67 million in 2021 and is estimated to reach $407.89 million by 2031, exhibiting a CAGR of 3.9% from 2022 to 2031.  

Patient-controlled analgesia (PCA) is an effective pain management technique that offers the patient control over their pain. These pumps deliver opioid painkillers such hydromorphone, fentanyl, and morphine. The pump is attached to an intravenous (IV) line, which is a small, flexible tube inserted into a vein. Normally, this medication is administered when the button is pressed. These pumps are medical devices that deliver the medications into a patient's body in controlled amounts. Analgesic pumps are increasingly used in clinical settings such as hospitals, nursing homes, and in home. The applications of these analgesic pumps for delivery of medications such as morphine, fentanyl and hydromorphone. The PCA pump have the advantages such as safe to use, patient satisfaction, less sedation, reduced medication, and the nursing team is informed by an alert when the pump is empty.

PCA is equipped with a computerized pump, which is often used by patients recovering from surgery. It is employed for post-operative management. It is a method of pain control that provides patients with the power to control their pain. In addition, PCA is beneficial for patients who find difficulty in consuming medication by mouth. In some cases, the dose is set and an additional dose can be administered by patients themselves just by pressing a button. The patient-controlled analgesia can be administered by various routes, including oral, intravenous, epidural, inhaled, nasal spray, and transcutaneous.  

Patient controlled analgesia pumps are used to treat acute, chronic, postoperative, and labor pain, particularly in individuals who are unable to receive oral medications. In cases of acute pain in which the initial opioid dose in urgent care was insufficient to relieve pain thus, patient-controlled analgesia pumps can be useful. Some examples of common cases include burns, trauma, pancreatitis, and vaso-occlusive pain crises. 

The growth of global patient controlled analgesia pumps market is majorly driven by increase in demand for analgesic pumps to relieve the pain such as cancer pain, orthopedic, and sickle cell crises pain, rise in number of surgical procedures which requires the analgesic pumps. However, lack of knowledge regarding advanced patient controlled analgesic pumps in emerging countries and regulations for product approval hinders the market growth. Conversely, increase in demand for patient controlled analgesic pumps and rise in technological advancements in analgesic pumps are anticipated to provide lucrative opportunities to the market players. The possibility of medication errors exists due to increase in disease burden. Thus, there is a need for advanced delivery systems that are safer, more efficient, and standardized. In addition, the introduction of advanced PCA pumps provides the lucrative growth opportunities for the market. 

Factors such as surge in geriatric population, rise in prevalence of chronic pain, and low cost are likely to propel the market. Moreover, rise in the number of individuals undergoing surgeries globally for cancer, or other ailments is likely to have a positive impact on the market growth. Rise in incidence of diseases such as cancer, sickle cell disease, and orthopedics has led to an increase in demand for patient controlled analgesic pump devices. For instance, according to the Centers for Disease Control and Prevention (CDC), estimated that approximately 100,000 Americans affected with sickle cell disease in May 2022. Thus, rise in prevalence of sickle cell disease has increased the uptake for PCA pumps and thus drives the market growth.  

The global patient controlled analgesia pumps market is segmented into type, application, end user, and region. By type, the market is categorized into electronic & wireless and mechanical. On the basis of application, the market is segregated into oncology & hematology, gastroenterology, and others. By end user, the market is classified into hospitals, ambulatory surgical centers, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). 

Major Key players that operate in the global patient controlled analgesia pumps market are: Ace-medical, Arcomed AG, B. Braun SE, Becton, Dickinson and Company, Changzhou Medical Bioengineering Co., Ltd., Fresenius SE and Co. KGaA, Henan Tuoren Medical Device Co., Ltd., ICU Medical, Inc., Micrel Medical Devices SA, SCW Medicath Ltd. 

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the patient controlled analgesia pumps market analysis from 2021 to 2031 to identify the prevailing patient controlled analgesia pumps market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the patient controlled analgesia pumps market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global patient controlled analgesia pumps market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

  • Electronic and Wireless
  • Mechanical

By Application

  • Oncology and hematology
  • Gastroenterology
  • Others

By End user

  • Hospitals
  • Ambulatory surgical centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players

  • Ace-medical
  • B. Braun SE
  • ICU Medical, Inc.
  • SCW Medicath Ltd
  • Changzhou Medical Bioengineering Co., Ltd.
  • Arcomed AG
  • Becton, Dickinson and Company
  • Henan Tuoren Medical Device Co., Ltd.
  • Fresenius SE and Co. KGaA
  • Micrel Medical Devices SA

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Moderate bargaining power of suppliers
    • 3.3.2. Moderate bargaining power of buyers
    • 3.3.3. Moderate threat of substitutes
    • 3.3.4. Moderate threat of new entrants
    • 3.3.5. Moderate intensity of rivalry
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Rise in cases of chronic pain diseases
      • 3.4.1.2. Technological advancements in analgesic pumps
      • 3.4.1.3. Increase in number of surgeries
    • 3.4.2. Restraints
      • 3.4.2.1. Lack of awareness regarding analgesia pumps
      • 3.4.2.2. Stringent government regulations
    • 3.4.3. Opportunities
      • 3.4.3.1. Lucrative growth opportunities in developing countries
      • 3.4.3.2. Development in analgesic pumps
  • 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Electronic and Wireless
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Mechanical
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Oncology and hematology
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Gastroenterology
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Others
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country

CHAPTER 6: PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Hospitals
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Ambulatory surgical centers
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Others
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key trends and opportunities
    • 7.2.2. Market size and forecast, by Type
    • 7.2.3. Market size and forecast, by Application
    • 7.2.4. Market size and forecast, by End user
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Key market trends, growth factors and opportunities
      • 7.2.5.1.2. Market size and forecast, by Type
      • 7.2.5.1.3. Market size and forecast, by Application
      • 7.2.5.1.4. Market size and forecast, by End user
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Key market trends, growth factors and opportunities
      • 7.2.5.2.2. Market size and forecast, by Type
      • 7.2.5.2.3. Market size and forecast, by Application
      • 7.2.5.2.4. Market size and forecast, by End user
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Key market trends, growth factors and opportunities
      • 7.2.5.3.2. Market size and forecast, by Type
      • 7.2.5.3.3. Market size and forecast, by Application
      • 7.2.5.3.4. Market size and forecast, by End user
  • 7.3. Europe
    • 7.3.1. Key trends and opportunities
    • 7.3.2. Market size and forecast, by Type
    • 7.3.3. Market size and forecast, by Application
    • 7.3.4. Market size and forecast, by End user
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Key market trends, growth factors and opportunities
      • 7.3.5.1.2. Market size and forecast, by Type
      • 7.3.5.1.3. Market size and forecast, by Application
      • 7.3.5.1.4. Market size and forecast, by End user
      • 7.3.5.2. France
      • 7.3.5.2.1. Key market trends, growth factors and opportunities
      • 7.3.5.2.2. Market size and forecast, by Type
      • 7.3.5.2.3. Market size and forecast, by Application
      • 7.3.5.2.4. Market size and forecast, by End user
      • 7.3.5.3. UK
      • 7.3.5.3.1. Key market trends, growth factors and opportunities
      • 7.3.5.3.2. Market size and forecast, by Type
      • 7.3.5.3.3. Market size and forecast, by Application
      • 7.3.5.3.4. Market size and forecast, by End user
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Key market trends, growth factors and opportunities
      • 7.3.5.4.2. Market size and forecast, by Type
      • 7.3.5.4.3. Market size and forecast, by Application
      • 7.3.5.4.4. Market size and forecast, by End user
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Key market trends, growth factors and opportunities
      • 7.3.5.5.2. Market size and forecast, by Type
      • 7.3.5.5.3. Market size and forecast, by Application
      • 7.3.5.5.4. Market size and forecast, by End user
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Key market trends, growth factors and opportunities
      • 7.3.5.6.2. Market size and forecast, by Type
      • 7.3.5.6.3. Market size and forecast, by Application
      • 7.3.5.6.4. Market size and forecast, by End user
  • 7.4. Asia-Pacific
    • 7.4.1. Key trends and opportunities
    • 7.4.2. Market size and forecast, by Type
    • 7.4.3. Market size and forecast, by Application
    • 7.4.4. Market size and forecast, by End user
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Key market trends, growth factors and opportunities
      • 7.4.5.1.2. Market size and forecast, by Type
      • 7.4.5.1.3. Market size and forecast, by Application
      • 7.4.5.1.4. Market size and forecast, by End user
      • 7.4.5.2. China
      • 7.4.5.2.1. Key market trends, growth factors and opportunities
      • 7.4.5.2.2. Market size and forecast, by Type
      • 7.4.5.2.3. Market size and forecast, by Application
      • 7.4.5.2.4. Market size and forecast, by End user
      • 7.4.5.3. India
      • 7.4.5.3.1. Key market trends, growth factors and opportunities
      • 7.4.5.3.2. Market size and forecast, by Type
      • 7.4.5.3.3. Market size and forecast, by Application
      • 7.4.5.3.4. Market size and forecast, by End user
      • 7.4.5.4. Australia
      • 7.4.5.4.1. Key market trends, growth factors and opportunities
      • 7.4.5.4.2. Market size and forecast, by Type
      • 7.4.5.4.3. Market size and forecast, by Application
      • 7.4.5.4.4. Market size and forecast, by End user
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Key market trends, growth factors and opportunities
      • 7.4.5.5.2. Market size and forecast, by Type
      • 7.4.5.5.3. Market size and forecast, by Application
      • 7.4.5.5.4. Market size and forecast, by End user
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Key market trends, growth factors and opportunities
      • 7.4.5.6.2. Market size and forecast, by Type
      • 7.4.5.6.3. Market size and forecast, by Application
      • 7.4.5.6.4. Market size and forecast, by End user
  • 7.5. LAMEA
    • 7.5.1. Key trends and opportunities
    • 7.5.2. Market size and forecast, by Type
    • 7.5.3. Market size and forecast, by Application
    • 7.5.4. Market size and forecast, by End user
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Key market trends, growth factors and opportunities
      • 7.5.5.1.2. Market size and forecast, by Type
      • 7.5.5.1.3. Market size and forecast, by Application
      • 7.5.5.1.4. Market size and forecast, by End user
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Key market trends, growth factors and opportunities
      • 7.5.5.2.2. Market size and forecast, by Type
      • 7.5.5.2.3. Market size and forecast, by Application
      • 7.5.5.2.4. Market size and forecast, by End user
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Key market trends, growth factors and opportunities
      • 7.5.5.3.2. Market size and forecast, by Type
      • 7.5.5.3.3. Market size and forecast, by Application
      • 7.5.5.3.4. Market size and forecast, by End user
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Key market trends, growth factors and opportunities
      • 7.5.5.4.2. Market size and forecast, by Type
      • 7.5.5.4.3. Market size and forecast, by Application
      • 7.5.5.4.4. Market size and forecast, by End user

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top player positioning, 2021

CHAPTER 9: COMPANY PROFILES

  • 9.1. Ace-medical
    • 9.1.1. Company overview
    • 9.1.2. Key Executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
  • 9.2. Arcomed AG
    • 9.2.1. Company overview
    • 9.2.2. Key Executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
  • 9.3. B. Braun SE
    • 9.3.1. Company overview
    • 9.3.2. Key Executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
    • 9.3.6. Business performance
  • 9.4. Becton, Dickinson and Company
    • 9.4.1. Company overview
    • 9.4.2. Key Executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Business performance
  • 9.5. Henan Tuoren Medical Device Co., Ltd.
    • 9.5.1. Company overview
    • 9.5.2. Key Executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
  • 9.6. ICU Medical, Inc.
    • 9.6.1. Company overview
    • 9.6.2. Key Executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
    • 9.6.6. Business performance
    • 9.6.7. Key strategic moves and developments
  • 9.7. Micrel Medical Devices SA
    • 9.7.1. Company overview
    • 9.7.2. Key Executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
  • 9.8. Fresenius SE and Co. KGaA
    • 9.8.1. Company overview
    • 9.8.2. Key Executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
    • 9.8.6. Business performance
  • 9.9. Changzhou Medical Bioengineering Co., Ltd.
    • 9.9.1. Company overview
    • 9.9.2. Key Executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
  • 9.10. SCW Medicath Ltd
    • 9.10.1. Company overview
    • 9.10.2. Key Executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio

LIST OF TABLES

  • TABLE 01. GLOBAL PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 02. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR ELECTRONIC AND WIRELESS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 03. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR MECHANICAL, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 04. GLOBAL PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 05. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR ONCOLOGY AND HEMATOLOGY, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 06. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR GASTROENTEROLOGY, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 07. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 08. GLOBAL PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 09. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR HOSPITALS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 10. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 11. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 12. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 13. NORTH AMERICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 14. NORTH AMERICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 15. NORTH AMERICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 16. NORTH AMERICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 17. U.S. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 18. U.S. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 19. U.S. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 20. CANADA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 21. CANADA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 22. CANADA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 23. MEXICO PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 24. MEXICO PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 25. MEXICO PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 26. EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 27. EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 28. EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 29. EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 30. GERMANY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 31. GERMANY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 32. GERMANY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 33. FRANCE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 34. FRANCE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 35. FRANCE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 36. UK PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 37. UK PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 38. UK PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 39. ITALY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 40. ITALY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 41. ITALY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 42. SPAIN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 43. SPAIN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 44. SPAIN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 45. REST OF EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 46. REST OF EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 47. REST OF EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 48. ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 49. ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 50. ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 51. ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 52. JAPAN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 53. JAPAN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 54. JAPAN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 55. CHINA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 56. CHINA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 57. CHINA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 58. INDIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 59. INDIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 60. INDIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 61. AUSTRALIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 62. AUSTRALIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 63. AUSTRALIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 64. SOUTH KOREA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 65. SOUTH KOREA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 66. SOUTH KOREA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 67. REST OF ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 68. REST OF ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 69. REST OF ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 70. LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 71. LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 72. LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 73. LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 74. BRAZIL PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 75. BRAZIL PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 76. BRAZIL PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 77. SAUDI ARABIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 78. SAUDI ARABIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 79. SAUDI ARABIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 80. SOUTH AFRICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 81. SOUTH AFRICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 82. SOUTH AFRICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 83. REST OF LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 84. REST OF LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 85. REST OF LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 86. ACE-MEDICAL: KEY EXECUTIVES
  • TABLE 87. ACE-MEDICAL: COMPANY SNAPSHOT
  • TABLE 88. ACE-MEDICAL: PRODUCT SEGMENTS
  • TABLE 89. ACE-MEDICAL: PRODUCT PORTFOLIO
  • TABLE 90. ARCOMED AG: KEY EXECUTIVES
  • TABLE 91. ARCOMED AG: COMPANY SNAPSHOT
  • TABLE 92. ARCOMED AG: PRODUCT SEGMENTS
  • TABLE 93. ARCOMED AG: PRODUCT PORTFOLIO
  • TABLE 94. B. BRAUN SE: KEY EXECUTIVES
  • TABLE 95. B. BRAUN SE: COMPANY SNAPSHOT
  • TABLE 96. B. BRAUN SE: PRODUCT SEGMENTS
  • TABLE 97. B. BRAUN SE: PRODUCT PORTFOLIO
  • TABLE 98. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
  • TABLE 99. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • TABLE 100. BECTON, DICKINSON AND COMPANY: PRODUCT SEGMENTS
  • TABLE 101. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
  • TABLE 102. HENAN TUOREN MEDICAL DEVICE CO., LTD.: KEY EXECUTIVES
  • TABLE 103. HENAN TUOREN MEDICAL DEVICE CO., LTD.: COMPANY SNAPSHOT
  • TABLE 104. HENAN TUOREN MEDICAL DEVICE CO., LTD.: PRODUCT SEGMENTS
  • TABLE 105. HENAN TUOREN MEDICAL DEVICE CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 106. ICU MEDICAL, INC.: KEY EXECUTIVES
  • TABLE 107. ICU MEDICAL, INC.: COMPANY SNAPSHOT
  • TABLE 108. ICU MEDICAL, INC.: PRODUCT SEGMENTS
  • TABLE 109. ICU MEDICAL, INC.: PRODUCT PORTFOLIO
  • TABLE 110. ICU MEDICAL, INC.: KEY STRATERGIES
  • TABLE 111. MICREL MEDICAL DEVICES SA: KEY EXECUTIVES
  • TABLE 112. MICREL MEDICAL DEVICES SA: COMPANY SNAPSHOT
  • TABLE 113. MICREL MEDICAL DEVICES SA: PRODUCT SEGMENTS
  • TABLE 114. MICREL MEDICAL DEVICES SA: PRODUCT PORTFOLIO
  • TABLE 115. FRESENIUS SE AND CO. KGAA: KEY EXECUTIVES
  • TABLE 116. FRESENIUS SE AND CO. KGAA: COMPANY SNAPSHOT
  • TABLE 117. FRESENIUS SE AND CO. KGAA: PRODUCT SEGMENTS
  • TABLE 118. FRESENIUS SE AND CO. KGAA: PRODUCT PORTFOLIO
  • TABLE 119. CHANGZHOU MEDICAL BIOENGINEERING CO., LTD.: KEY EXECUTIVES
  • TABLE 120. CHANGZHOU MEDICAL BIOENGINEERING CO., LTD.: COMPANY SNAPSHOT
  • TABLE 121. CHANGZHOU MEDICAL BIOENGINEERING CO., LTD.: PRODUCT SEGMENTS
  • TABLE 122. CHANGZHOU MEDICAL BIOENGINEERING CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 123. SCW MEDICATH LTD: KEY EXECUTIVES
  • TABLE 124. SCW MEDICATH LTD: COMPANY SNAPSHOT
  • TABLE 125. SCW MEDICATH LTD: PRODUCT SEGMENTS
  • TABLE 126. SCW MEDICATH LTD: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031
  • FIGURE 02. SEGMENTATION OF PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031
  • FIGURE 03. TOP INVESTMENT POCKETS IN PATIENT CONTROLLED ANALGESIA PUMPS MARKET (2022-2031)
  • FIGURE 04. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 05. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 06. MODERATE THREAT OF SUBSTITUTES
  • FIGURE 07. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 08. MODERATE INTENSITY OF RIVALRY
  • FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALPATIENT CONTROLLED ANALGESIA PUMPS MARKET
  • FIGURE 10. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR ELECTRONIC AND WIRELESS, BY COUNTRY 2021-2031(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR MECHANICAL, BY COUNTRY 2021-2031(%)
  • FIGURE 13. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR ONCOLOGY AND HEMATOLOGY, BY COUNTRY 2021-2031(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR GASTROENTEROLOGY, BY COUNTRY 2021-2031(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 17. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR HOSPITALS, BY COUNTRY 2021-2031(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY 2021-2031(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 21. PATIENT CONTROLLED ANALGESIA PUMPS MARKET BY REGION, 2021
  • FIGURE 22. U.S. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 23. CANADA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 24. MEXICO PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 25. GERMANY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 26. FRANCE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 27. UK PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 28. ITALY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 29. SPAIN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 30. REST OF EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 31. JAPAN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 32. CHINA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 33. INDIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 34. AUSTRALIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 35. SOUTH KOREA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 36. REST OF ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 37. BRAZIL PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 38. SAUDI ARABIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 39. SOUTH AFRICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 40. REST OF LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 41. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 42. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 43. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 44. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 45. COMPETITIVE DASHBOARD
  • FIGURE 46. COMPETITIVE HEATMAP: PATIENT CONTROLLED ANALGESIA PUMPS MARKET
  • FIGURE 47. TOP PLAYER POSITIONING, 2021
  • FIGURE 48. B. BRAUN SE: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 49. B. BRAUN SE: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 50. B. BRAUN SE: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 51. BECTON, DICKINSON AND COMPANY: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 52. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 53. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 54. ICU MEDICAL, INC.: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 55. ICU MEDICAL, INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 56. ICU MEDICAL, INC.: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 57. FRESENIUS SE AND CO. KGAA: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 58. FRESENIUS SE AND CO. KGAA: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 59. FRESENIUS SE AND CO. KGAA: REVENUE SHARE BY REGION, 2021 (%)